Pulling SEC filings + quote and writing the call…
CATX
Perspective Therapeutics, Inc.
Next earnings ≈ Aug 10, 2026 · est. from filing cadence
Last earnings +3.2% on 2026-05-11
$3.05
▲ +3.39%$3.05▼ -15.51%
over 1Y
L $2.05EODHDH $5.65
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+3.4%
1W+3.7%
1M-26.7%
3M-28.1%
YTD+9.3%
1Y-15.5%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 20 analysts
Buy
Conservative balance sheet (liabilities/equity 0.29x); but unprofitable (net margin -7191.1%).
Perspective Therapeutics, Inc. shows $1.43M in FY2023 revenue, a -7191.1% net margin, and -49.8% ROE.
Sources: SEC EDGAR (CIK 0000728387, latest 10-Q filed 2026-05-11) · EODHD · as of 6/23/2026, 4:03:38 AM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.